| Literature DB >> 31214980 |
Isabel Zegri-Reiriz1, F Javier de Haro-Del Moral2, Fernando Dominguez1,3,4, Clara Salas3,5, Pablo de la Cuadra6, Aresio Plaza7, Isabel Krsnik8, Esther Gonzalez-Lopez1,3,4, Pablo Garcia-Pavia9,10,11.
Abstract
Carpal tunnel syndrome (CTS) is a common finding among patients with cardiac amyloidosis. We sought to determine the prevalence of cardiac amyloidosis in patients who had undergone CTS surgery. From 2005 to 2014, 308 patients ≥ 60 years underwent CTS surgery. Of these, 233 (76%) agreed to participate in the study and 101 (73 ± 8 years; 68% females) showed left ventricular hypertrophy (LVH) ≥ 12 mm and underwent additional studies to diagnose AL and ATTR amyloidosis. Based on complementary studies, three patients were diagnosed with cardiac amyloidosis (two wild-type ATTR and one AL). The three patients showed bilateral CTS with no occupational risk factors. Prevalence of cardiac amyloidosis in the overall cohort was only 1.2% (3/233), but among patients with LVH and bilateral CTS, the prevalence was 5.5% (3/55) and 13.6% (3/22) if cases with an occupational risk factor were excluded. Cardiac amyloidosis should be excluded in the presence of bilateral CTS and particularly if an occupational risk factor is absent.Entities:
Keywords: Amyloidosis; Carpal tunnel syndrome; Tansthyretin
Mesh:
Year: 2019 PMID: 31214980 DOI: 10.1007/s12265-019-09895-0
Source DB: PubMed Journal: J Cardiovasc Transl Res ISSN: 1937-5387 Impact factor: 4.132